Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Hopkins, Claire*" or (type exact bookEditor and editor="Hopkins, Claire*")

Add to list
- Journal Article
- A1
- open access
Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Joseph K. Han, Claus Bachert (UGent) , Stella E. Lee, Claire Hopkins, Enrico Heffler, Peter Hellings (UGent) , Anju T. Peters, Siddhesh Kamat, Diane Whalley, Shanshan Qin, et al.

(2022) LARYNGOSCOPE. 132(2). p.265-271
Add to list
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial

Claus Bachert (UGent) , Joseph K. Han, Martin Y. Desrosiers, Philippe Gevaert (UGent) , Enrico Heffler, Claire Hopkins, Jody R. Tversky, Peter Barker, David Cohen, Claire Emson, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(4). p.1309-1317.e12
Add to list
- Journal Article
- A1
- open access
Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps

Asif H. Khan (UGent) , Matthew Reaney, Isabelle Guillemin, Lauren Nelson, Shanshan Qin, Siddhesh Kamat, Leda Mannent, Nikhil Amin, Diane Whalley and Claire Hopkins

(2022) LARYNGOSCOPE. 132(5). p.933-941
Add to list
- Conference Paper
- C3
Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Andrew Lane, Joaquim Mullol, Claire Hopkins, Wytske Fokkens, Stella Lee, Asif H. Khan (UGent) , Jérôme Msihid, Scott Nash, Shahid Siddiqui, Urvi Mujumdar, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB144-AB144
Add to list
- Conference Paper
- C3
Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps

Claire Hopkins, Stella Lee, Wytske Fokkens, Eugene Chang, Jérôme Msihid, Asif H. Khan (UGent) , Urvi Mujumdar, Siddhesh Kamat, Scott Nash, Shahid Siddiqui, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB142-AB142
Add to list
- Journal Article
- A1
- open access
Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
- Journal Article
- A1
- open access
Mepolizumab for chronic rhinosinusitis with nasal polyps : treatment efficacy by comorbidity and blood eosinophil count

Claus Bachert (UGent) , Ana R. Sousa, Joseph K. Han, Rodney J. Schlosser, Leigh J. Sowerby, Claire Hopkins, Jorge F. Maspero, Steven G. Smith, Oliver Kante, Despina E. Karidi-Andrioti, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(5). p.1711-1721.e6
Add to list
- Journal Article
- A1
- open access
Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien-Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review

Christine Kim, Joseph Han, Tara Wu, Claus Bachert (UGent) , Wytske Fokkens, Peter Hellings (UGent) , Claire Hopkins, Stella Lee, Joaquim Mullol and Jivianne T. Lee

(2021) OTOLARYNGOLOGY-HEAD AND NECK SURGERY. 164(1). p.57-66
Add to list
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE) : a randomised, double-blind, placebo-controlled, phase 3 trial

Joseph K Han, Claus Bachert (UGent) , Wytske Fokkens, Martin Desrosiers, Martin Wagenmann, Stella E Lee, Steven G Smith, Neil Martin, Bhabita Mayer, Steven W Yancey, et al.

(2021) LANCET RESPIRATORY MEDICINE. 9(10). p.1141-1153

Academic Bibliography

Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial

Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps

Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps

Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Mepolizumab for chronic rhinosinusitis with nasal polyps : treatment efficacy by comorbidity and blood eosinophil count

Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE) : a randomised, double-blind, placebo-controlled, phase 3 trial

Contents

Support

Contact